22.6 C
New York
Saturday, June 13, 2026

Tag: Precisely

MarketsandMarkets’ 360Quadrants Recognizes Top Startups and SMEs in the Hospital Information System Quadrant Report 2025

DELRAY BEACH, Fla., Aug. 8, 2025 /PRNewswire/ -- 360Quadrants has released its latest Hospital Information System Startups/SMEs, 2025, recognizing key players, including both global...

All-new 2026 Dodge Charger Scat Pack Drops the Hammer With 550 Horsepower, AWD Fury and Gasoline-powered Old-school Attitude as Most Powerful Car Under $55,000

AUBURN HILLS, Mich., Aug. 8, 2025 /PRNewswire/ -- 2026 Dodge Charger Scat Pack, powered by the turbocharged SIXPACK high-output (H.O.) engine, clocks a 3.9-second 0-60 time...

Genpact Reports Second Quarter 2025 Results

Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency)1Data-Tech-AI Net Revenues of $599 million, Up 9.7% (9.5% constant currency)1Digital Operations Net Revenues of...

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025 Initiated ALKAZAR...

US NCI Sponsors Senhwa Biosciences’ Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma

TAIPEI and SAN DIEGO, Aug. 7, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

Thyseed Newborn Baby Bottle with Bottom Vent Design: Clinically Proven to Reduce Colic and Spit-up by 30%

New anti-colic system delivers clinically tested relief for newborn digestive discomfort BEIJING, Aug. 6, 2025 /PRNewswire/ -- Thyseed, an established name in global infant care,...

Thyseed Newborn Baby Bottle with Bottom Vent Design: Clinically Proven to Reduce Colic and Spit-up by 30%

New anti-colic system delivers clinically tested relief for newborn digestive discomfort BEIJING, Aug. 6, 2025 /PRNewswire/ -- Thyseed, an established name in global infant care,...

JELD-WEN Reports Second Quarter 2025 Results and Reinstates Full Year Guidance

CHARLOTTE, N.C., Aug. 5, 2025 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD) ("JELD-WEN" or the "Company") today announced results for the three and six...

Why XentaFlex Is Emerging as 2025’s Most Affordable, Simplest, and Most Effective Joint Pain Solution

More Americans Are Rethinking Collagen, Glucosamine, and Pills in 2025 as Public Curiosity Shifts Toward Ingredient-First Joint Hydration Formulas Like Simple Promises' XentaFlex
More Americans Are Rethinking Collagen, Glucosamine, and Pills in 2025 as Public Curiosity Shifts Toward Ingredient-First Joint Hydration Formulas Like Simple Promises' XentaFlex

Haut.AI Named Winner of the 2025 BeautyMatter Awards for Best Breakthrough Technology (Omnichannel)

NEW YORK, Aug. 4, 2025 /PRNewswire/ -- Haut.AI, a technology company transforming beauty retail through generative AI and omnichannel personalization, is honored to announce that...

Liquid Youth Named Winner of Best Breakthrough Wellness Brand in the 2025 BeautyMatter Awards

Liquid Youth has been awarded Best Breakthrough Wellness Brand in the 2025 BeautyMatter Awards.

Lighting and Decorative Fixtures: Unlocking Immense Business Opportunities + Professional Platforms – Cracking the Code of Business Growth

ZHONGSHAN, China, Aug. 4, 2025 /PRNewswire/ -- The 33rd China (Guzhen) International Lighting Fair (hereinafter referred to as "Guzhen Lighting Fair") is scheduled to...

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPrecisely